Vivos Therapeutics (VVOS) Operating Income Growth (3y) (2023 - 2026)
Vivos Therapeutics (VVOS) Operating Income Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -3.76% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 8.39% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.17% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 25.88% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 7.13% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 75.54% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 34.83% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -2.70% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Vivos Therapeutics | 3.62 Mn | 1.38 Mn | 3.06 Mn | -9.74% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.74% |
| Dec 31, 2025 | -1.72% |
| Sep 30, 2025 | 4.33% |
| Jun 30, 2025 | 11.27% |
| Mar 31, 2025 | 16.12% |
| Dec 31, 2024 | 27.66% |
| Sep 30, 2024 | 21.67% |
| Jun 30, 2024 | 21.88% |
| Mar 31, 2024 | -3.58% |
| Dec 31, 2023 | 12.87% |
| Sep 30, 2023 | -26.06% |
| Jun 30, 2023 | -47.16% |
| Mar 31, 2023 | -25.08% |